Member Info for Wilson63

Not cross boarding but I hold seeing machines I held all the way up bought i. the 11's as well and held all the way down went under 2p(during trading) held all the way(so) and purchased as I went only in small blocks I'm a happy camper with that I believed/believe in it.

Exactly same here adding small amounts as I can as I BELIEVE in the company yes it's painful but I've increased my holding significantly(still not huge).
Some people are getting sucked in by the mega deramp brigade, stand back look at what the company has in the pipeline.

Presuming Zimbabwe haven't payed(where's page 4 B2) it's a govt it's not Novacyt fault for feck sake They had enough money to buy trolley loads of whisky in Glasgow the other day.

Sorry for the waffle I'll be doing my homework tomorrow.

Not by the Jam(great band) but Novacyt q machines Tks Larry

https://twitter.com/Larry64450205/status/1455769079864758275

Off out gla.

Crl you genuinely don't know about the lab innovations exhibition tomorrow and Thursday? If not it's at the NEC not on webinair you've surprised me with that.

Globetrotter thought you sold?

https://coronavirus.data.gov.uk/

Full figures.

Approx 167 mil market cap haha he cackled like a demented man unsure how the so called rational of the markets could arrive at this number.

Agree Airlineboy alas I made a significant (for me) but yesterday as I still fully expect co-prep to land imminently. DA will have signed off on the Rns but it appears as with GM he isn't the one writing it as it seems identical how it comes out.

Back in august

Primerdesign, a wholly owned subsidiary of Novacyt, has been awarded a new contract under the PHE National Microbiology Framework, effective immediately, for the supply of PROmate® COVID-19 tests to the NHS. The PROmate® COVID-19 tests have been developed to run on the Company's q16 and q32 PCR instrument platforms. The q16 and q32 near patient PCR instrument platforms using the PROmate® COVID-19 test have been validated and can be used at select NHS hospitals. The contract is valued at up to £4.7m and will last until 31 March 2022. There are no minimum purchase levels as part of this contract.

31st March is the interesting part here, so contract is up until 31st March(I know govt and contracts) So they still intend to be dealing with us after their temporary extension has expired.

Some embarrassing non invested post this morning mind you I always preferred esso.

Airlineboy Tks for the list.

I was just attempting to be humorous:(((
Shall catch up on the day now to see what I've missed.

See they've started the share buy back then.

:))))

Tks to Larry SNPsig

Specific reverse-transcription PCR assays to detect SNPs are used to identify known variants. Although this method is relatively low-throughput, slow, and requires sequencing to confirm the presence of variants, it is highly accurate. For instance, the CoronaMeltVAR Real-Time PCR detection kit uses melting curve analysis to detect the Alpha, Beta, and Gamma SARS-CoV-2 variants in nasopharyngeal and oropharyngeal samples. Primerdesign provides a series of diagnostic real-time reverse-transcriptase PCR assays, SNPsig kits, that use SNPs to detect various SARS-CoV-2 variants of concern.

Full article

https://www.clinicallabmanager.com/trends/covid-19-testing/tracking-emerging-covid-19-variants-26012

Bit far for me

https://twitter.com/NovacytGroup/status/1454876074471563265

Hi Gizmo555 it's like a one stop summary of our company

https://www.medica-tradefair.com/vis/v1/en/exhibitors/medcom2021.2691623

The new CO-Prep™ instrument has received significant interest from customers in advance of the launch next month. PROmate™ and Co-Prep™ have currently been designed for testing of COVID-19, but both testing and instrument technologies can be used to target additional diseases in the future.

From this Rns

https://www.lse.co.uk/rns/NCYT/rd-update-00oexdtagnjlkgw.html

I'm aware we have slightly overrun.

This

Overall, UK private market sales, which currently includes COVID-19 testing in film, media, travel and corporate industries, increased significantly in Q2 2021 compared to Q1 2021. The Company believes it is well placed to continue to support this growth during the second half of the year.



As part of its expansion in private testing, the Company has also signed a supply contract initially for genesig® COVID-19 products with Excalibur Healthcare Services, who have invested in new laboratory services in Cambridge, UK, to support COVID-19 testing of private clients.

Wonder how Excalibur are viewing co-prep.

In fairness this

https://www.lse.co.uk/rns/NCYT/half-year-2021-results-25htu0dw34gr5u4.html

It's an aladdins cave of potential to be frank at this price if you have patience and a bit of steel about you well. Not financial advice Dyor trust in your research.

Held......Holding........Hold.

Bump

I'm a low value(in monetary terms)investor who's much better researched than some of the apparently high value(conceited ....)investors on here.
I'd presume you will be attending the NEC this week oh wait your working illegally seven days a week... what did jim Royle say My Arse.

Sharestack that's correct so it's good to see them getting some traction elsewhere.

I'd seen the original feature medical traile(I'd think!!) but Kilkenny ted for me had turned this up I'm pretty sure I've not seen this one reads well anyway Tks KT the more the merrier.

https://www.ukas.com/wp-content/uploads/schedule_uploads/973605/22275-Medical-Multiple.pdf

Airlineboy I second your comments, good to see you here also, now I'm off to that strange place called WORK. Catch you later.

Valju spendspend spend was in the sixties and if you pay rubbish sometimes you just get...well rubbish.